We report the characterization of a domain of the major timothy grass pollen allergen, Phl p 5A, which contains the binding site for a human monoclonal IgE antibody. The human monoclonal IgE antibody fragment (Fab) was obtained from an IgE combinatorial library constructed from lymphocytes of a grass pollen-allergic patient. An 11.2-kD N-terminal fragment representing approximately one third of the complete Phl p 5A allergen could be identified to contain the binding site for the IgE Fab. The rPhl p 5A fragment revealed an extremely high allergenic activity in skin test experiments which in some cases equaled that of the complete Phl p 5A allergen. The rPhl p 5A domain thus represents an allergen fragment containing several IgE epitopes in a configuration optimal for efficient effector cell activation. We suggest the rPhl p 5A fragment and the corresponding IgE Fab as paradigmatic tools to explore the structural requirements for highly efficient effector cell activation.

Keywords:
Monoclonal human IgE, Allergen, Epitope
1.
Valenta R, Kraft D: Recombinant allergens for diagnosis and therapy of allergic diseases. Curr Opin Immunol 1995;7:751–756.
2.
Valenta R, Almo S, Ball B, Dolecek C, Steinberger P, Laffer S, Eibensteiner P, Flicker S, Vrtala S, Spitzauer S, Valent P, Denepoux S, Kraft D, Banchereau J, Lebecque S: The immunoglobulin E-allergen interaction: A target for therapy of type I allergic diseases. Int Arch Allergy Immunol 1998;16:167–176.
3.
Valenta R, Vrtala S, Laffer S, Spitzauer S, Kraft D: Recombinant allergens. Allergy 1998;53:552–561.
4.
Burton DR, Barbas CF: Human antibodies from combinatorial libraries. Adv Immunol 1994;57:191–280.
5.
Steinberger P, Kraft D, Valenta R: Construction of a combinatorial IgE library from an allergic patient. J Biol Chem 1996;271:10967–10972.
6.
Vrtala S, Sperr WR, Reimitzer I, van Ree R, Laffer S, Müller WD, Valent P, Rumpold H, Kraft D, Scheiner O, Valenta R: cDNA cloning of a major allergen from timothy grass (Phleum pratense) pollen; characterization of the recombinant Phl p V allergen. J Immunol 1993;151:4773–4781.
7.
Heiss S, Mahler V, Steiner R, Spitzauer S, Schweiger C, Kraft D, Valenta R: Component-resolved diagnosis (CDR) of type I allergy with recombinant grass and tree pollen allergens by skin testing. J Invest Dermatol 1999;113:830–837.
8.
Vrtala S, Ball T, Spitzauer S, Pandjaitan B, Suphioglu C, Knox B, Sperr WR, Valent P, Kraft D, Valenta R: Immunization with purified natural and recombinant allergen induces mouse IgG1 antibodies that recognize similar epitopes as human IgE and inhibit the human IgE-allergen interaction and allergen-induced basophil degranulation. J Immunol 1998;160:6137–6144.
9.
Devereux J, Haeberli P, Smithies O: A comprehensive set of analysis programs for the VAX. Nucleic Acids Res 1984;12:387–395.
10.
Thompson JD, Higgins DG, Gibson TJ: CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 1994;22:4673–4680.
11.
Rost B, Sander C: Prediction of protein secondary structure at better than 70% accuracy. J Mol Biol 1993;232:584–599.
12.
Rost B, Sander C: Combining evolutionary information and neural networks to predict protein secondary structure. Proteins 1994;20:216–226.
13.
Vrtala S, Hirtenlehner K, Vangelista L, Pastore A, Eichler HG, Sperr WR, Valent P, Ebner C, Kraft D, Valenta R: Conversion of the major birch pollen allergen, Bet v 1, into two nonanaphylactic T cell epitope-containing fragments: Candidates for a novel form of specific immunotherapy. J Clin Invest 1997;99:1673–1681.
14.
Flicker S, Vrtala S, Steinberger P, Vangelista L, Bufe A, Petersen A, Ghannadan M, Sperr WR, Valent P, Norderhaug L, Bohle B, Stockinger H, Suphioglu C, Ong EK, Kraft D, Valenta R: A human monoclonal IgE antibody defines a highly allergenic fragment of the major timothy grass pollen allergen, Phl p 5: Molecular, immunological, and structural characterization of the epitope-containing domain. J Immunol 2000;165: in press.
15.
Bufe A, Gelhar K, Schramm G, Schlaak M, Becker WM: Allergenic activity of a major pollen allergen is elevated in the presence of nasal secretion. Am J Respir Crit Care Med 1998;157:1269–1276.
16.
MacGlashan D, Lichtenstein LM: Studies of antigen binding on human basophils. I. Antigen binding and functional consequences. J Immunol 1983;130:2330–2336.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.